Alkermes PLC (ALKS) stock fell 9.29% to $26.51 on Jul 21, down from its previous close of $29.22. The stock is 27.28% below its 52-week high and 8.29% above its 52-week low. Analysts forecast an average target price of $41.67, implying an upside of 57.20% from the current price. The estimated GF Value for Alkermes PLC in one year is $27.17, suggesting a 2.51% upside from the current price.
Alkermes PLC (ALKS) stock experienced a significant decline on July 21, dropping 9.29% to $26.51 from its previous close of $29.22. The stock now stands 27.28% below its 52-week high of $36.45 and is 8.29% above its 52-week low of $24.48. The trading volume on that day was 2,991,132 shares, representing a 179.2% increase over the average daily volume of 1,668,813 shares [2].
Analysts forecast an average target price of $41.67 for Alkermes PLC, suggesting an upside of 57.20% from the current price. The consensus recommendation from 17 brokerage firms is "Outperform," with an average brokerage recommendation of 2.1. Additionally, GuruFocus estimates the GF Value for Alkermes PLC to be $27.17, indicating a potential 2.51% upside from the current price [2].
Despite the recent drop, Alkermes is expected to report earnings for the quarter ended June 2025 on July 29. The market anticipates a year-over-year decline in earnings on lower revenues, with a Zacks Consensus Estimate of $0.41 per share, representing a 43.1% decrease. Analysts have revised the consensus EPS estimate 1.03% lower over the last 30 days, reflecting a more cautious outlook [1].
The Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting analysts have become more bullish on the company's earnings prospects. This results in an Earnings ESP of +4.94%, indicating a likely earnings beat. However, the stock carries a Zacks Rank of #3, which could limit the predictive power of the Earnings ESP [1].
Historically, Alkermes has beaten consensus EPS estimates just once out of the last four quarters, with the last reported quarter seeing a surprise of -53.57%. While the Earnings ESP and Zacks Rank suggest an earnings beat, the stock's recent price decline and historical performance warrant caution [1].
Investors should monitor the earnings report closely and consider other factors influencing the stock's performance. Staying informed about upcoming earnings announcements and using tools like the Zacks Earnings Calendar can provide valuable insights into the company's financial health and market outlook [1].
References:
[1] https://www.nasdaq.com/articles/alkermes-alks-expected-beat-earnings-estimates-should-you-buy
[2] https://www.gurufocus.com/news/2991220/alkermes-plc-alks-stock-price-down-929-on-jul-21
Comments
No comments yet